Phase 1 Metabolic Dysfunction-Associated Steatotic Liver Disease Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)

Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis

Regeneron Pharmaceuticals132 enrolled3 locationsNCT06836609

Recruiting

Phase 1

Developing Microbial Therapy for MASLD: From Mechanism to Clinical Validation

Metabolic Dysfunction-Associated Steatotic Liver Disease

Leeuwenhoek Laboratories Co. Ltd.40 enrolled1 locationNCT07488975